NUCATS' efforts to speed preclinical translation are housed in our Center for Translational Innovation (CTI). The Innovation and New Ventures Office (INVO) partnered with NUCATS to create the CTI. Despite Northwestern University's relatively small size, we have one of the most robust drug pipelines in the country because of strengths in neurosciences, oncology, immunology, and especially chemistry. NU has led all universities in the United States in life sciences income from licensing for the past several years. NU has designed and deployed a complete infrastructure for academic, therapeutic preclinical and clinical drug development.
CTI by the numbers:
In 2013, the Center for Translational Innovation (CTI) supported:
- 110 biomedical inventions, representing >50% of all inventions at Northwestern
- Executed 66 external agreements with external partners in public-private biomedical ventures
- Filed 197 patent applications in biomedical discovery and launched 4 biomedical start-up companies
- Supported 20 faculty members by Chicago Innovation Mentors (CIM) teams through NUCATS
"The most effective way to ensure a rich and sustainable pipeline of innovations is through the creation of a culture of translation and innovation. Towards this end CTI develops programs and activities to support Northwestern’s entrepreneurial environment for faculty, staff and students."
Alicia Loffler, PhD
Executive Director of INVO
Associate Vice President for Research
Associate Director for CTI
An overview of CTI.
The leadership and governance structure of CTI.
Discover how CTI can help take your research from benchside to bedside.
Find out more about how researchers have used our resources and services to great success.
Read articles related to CTI's work and impact.